Log in

NASDAQ:RCEL - AVITA MED LTD/S Stock Price, Forecast & News

+0.59 (+7.71 %)
(As of 12/16/2019 07:19 AM ET)
Today's Range
Now: $8.24
50-Day Range
MA: $8.45
52-Week Range
Now: $8.24
Volume571,682 shs
Average Volume580,327 shs
Market Capitalization$680.79 million
P/E RatioN/A
Dividend YieldN/A
Avita Medical Limited operates as a regenerative medicine company in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients 18 years and older. The company is based in Valencia, California.

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Current SymbolNASDAQ:RCEL



Sales & Book Value

Annual Sales$5.51 million
Book Value$0.26 per share



Market Cap$680.79 million
Next Earnings DateN/A
OptionableNot Optionable

Receive RCEL News and Ratings via Email

Sign-up to receive the latest news and ratings for RCEL and its competitors with MarketBeat's FREE daily newsletter.

AVITA MED LTD/S (NASDAQ:RCEL) Frequently Asked Questions

What is AVITA MED LTD/S's stock symbol?

AVITA MED LTD/S trades on the NASDAQ under the ticker symbol "RCEL."

What price target have analysts set for RCEL?

1 analysts have issued 12-month target prices for AVITA MED LTD/S's stock. Their forecasts range from $12.00 to $12.00. On average, they anticipate AVITA MED LTD/S's share price to reach $12.00 in the next twelve months. This suggests a possible upside of 45.6% from the stock's current price. View Analyst Price Targets for AVITA MED LTD/S.

What is the consensus analysts' recommendation for AVITA MED LTD/S?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AVITA MED LTD/S in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for AVITA MED LTD/S.

Has AVITA MED LTD/S been receiving favorable news coverage?

News articles about RCEL stock have been trending somewhat negative this week, according to InfoTrie Sentiment. InfoTrie identifies positive and negative media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. AVITA MED LTD/S earned a news impact score of -1.7 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the stock's share price in the immediate future. View News Stories for AVITA MED LTD/S.

Who are some of AVITA MED LTD/S's key competitors?

What other stocks do shareholders of AVITA MED LTD/S own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AVITA MED LTD/S investors own include AVITA MED LTD/S (AVMXY), Roku (ROKU), Bristol-Myers Squibb (BMY), Canopy Growth (CGC), Veeva Systems (VEEV), Agile Therapeutics (AGRX), Advanced Micro Devices (AMD), Cisco Systems (CSCO), Intellia Therapeutics (NTLA) and NVIDIA (NVDA).

How do I buy shares of AVITA MED LTD/S?

Shares of RCEL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is AVITA MED LTD/S's stock price today?

One share of RCEL stock can currently be purchased for approximately $8.24.

How big of a company is AVITA MED LTD/S?

AVITA MED LTD/S has a market capitalization of $680.79 million and generates $5.51 million in revenue each year. The company earns $-24,750,000.00 in net income (profit) each year or ($0.39) on an earnings per share basis. View Additional Information About AVITA MED LTD/S.

What is AVITA MED LTD/S's official website?

The official website for AVITA MED LTD/S is http://www.avitamedical.com/.

How can I contact AVITA MED LTD/S?

AVITA MED LTD/S's mailing address is 28159 Avenue Stanford Suite 220, Valencia CA, 91355. The company can be reached via phone at 661-367-9170 or via email at [email protected]

MarketBeat Community Rating for AVITA MED LTD/S (NASDAQ RCEL)

Community Ranking:  3.5 out of 5 (star star star half star)
Outperform Votes:  16 (Vote Outperform)
Underperform Votes:  7 (Vote Underperform)
Total Votes:  23
MarketBeat's community ratings are surveys of what our community members think about AVITA MED LTD/S and other stocks. Vote "Outperform" if you believe RCEL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RCEL will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel